PRIME-NL研究:在动态环境中评估帕金森病患者的复杂医疗干预措施
Bart R Maas1, Robin van den Bergh1, Sanne W van den Berg1
1Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Center of Expertise for Parkinson and Movement Disorders, Radboud university medical center, Nijmegen, The Netherlands.
BMC neurology
|August 3, 2024
概括
该PRIME-NL研究调整了其帕金森氏症研究.
科学领域:
- 医疗保健研究方法的方法.
- 帕金森病的护理模型
背景情况:
- PRIME帕金森综合护理模式在荷兰实施.
- 在PRIME-NL研究中,该模型得到了前性评估.
- 由于COVID-19危机造成了显著的延误和招聘挑战.
研究的目的:
- 详细说明PRIME-NL研究协议的方法调整.
- 为了应对COVID-19大流行和实施延迟所带来的挑战.
主要方法:
- 创新和常规护理地区之间的比较分析,使用医疗保健索赔数据.
- 每年向帕金森病患者,护理人员和医疗保健专业人员管理的问卷.
- 四个关键调整:延长评估期,纳入过程措施,实施反循环,更新分析计划.
主要成果:
- 调整了研究设计和分析以减轻外部影响.
- 方法的灵活性确保了尽管有动态的环境因素,持续评估.
结论:
- 该研究为调整复杂的医疗评估提供了透明度.
- 记录的解决方案为在动态环境中进行类似研究提供了一个模板.
- 确保在意外中断的情况下对创新的帕金森病护理模式进行强有力的评估.
相关概念视频
Parkinson's Disease: Treatment
241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
Parkinson's Disease: Overview
508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508


